Forecast: Basic Pharmaceutical Products and Preparations Manufacturing Output in the US

The manufacturing output of basic pharmaceutical products and preparations in the US has shown a steady growth from 2013 to 2023. Starting at $233.47 billion in 2013, it has reached $341.23 billion in 2023, indicating robust industry growth. The year-on-year growth presented moderate fluctuations, with significant jumps in 2015 (6.94%), 2019 (7.98%), and 2021 (8.15%), counterbalanced by minor declines in 2017 (-3.02%). Over the last five years, the Compound Annual Growth Rate (CAGR) stood at 4.58%. Forecasted data from 2024 to 2028 predict continued growth, albeit at a slower pace, with a five-year CAGR of 1.79%, and an overall forecasted growth rate of 9.3% by 2028.

Future trends to watch for include:

• Innovations in biotechnology and personalized medicine.
• Increasing investments in R&D for rare and chronic diseases.
• Potential impacts of regulatory changes.
• Adoption of digital transformation in manufacturing processes.